Other Industry Events

Jump To:

Phacilitate Leaders World

January 22–25, 2019

In a disruptive, cutting-edge industry like ours, no single person or entity has all of the answers. By bringing together a diverse range of expertise from across the advanced therapies ecosystem, Phacilitate is creating a network of partnerships and relationships that bring us closer to achieving the ultimate goal of improving patient care and developing commercially viable curative treatments.

We bring people together through award-winning events, which focus on the business and the science of advanced therapies. Phacilitate Leaders World and Phacilitate Leaders Europe are the pillars of our calendar and bring together the entire advanced therapies ecosystem.

5th Annual Immuno-Oncology 360˚

February 6–8, 2019

The Immuno-Oncology 360° Summit reports on the rapid advancements of clinical, scientific and business developments of IO in one setting for a wider range of cancers at an accelerated rate. Now in its 5th year, IO360° is a strategic-level meeting for decision-makers. The three-day event features 10 plenary sessions with over 80 speakers and includes more than ten hours of networking.  There will be over 450 attendees representing pharma, biotechs, academia, research organizations, and the investment community concentrating on IO.

FoCUS Paying for Cures: Ensuring Patient Access and System Sustainability

February 12, 2018

Join other policy and healthcare innovation leaders to grasp the challenges and explore solutions to making cures accessible to patients and sustainable by the healthcare system.

  • Understand the future of curative therapies and their financing challenges
  • Learn new Precision Financing strategies and tools
  • Connect with system stakeholders to solve problems

Registration is free but seating is extremely limited. Please reserve your seat today.

See the agenda and learn more at http://payingforcures.orgHosted by MIT Center for Biomedical Innovation NEWDIGS Initiative.

BIO-Europe Spring® 2019 — 13th International Partnering Conference

March 25–27, 2019

BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.

Gene Therapy for Rare Disorders 2019

March 26–28, 2019

Gene Therapy for Rare Disorders is a uniquely focused conference that will unite the leaders in this field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future.

Join 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.

Access the official event guide for the complete agenda and speaker line-up.

World Advanced Therapies & Regenerative Medicine Congress & Expo 2019

May 15–17, 2019

Celebrating 14 years, the World Advanced Therapies & Regenerative Medicine Congress has grown to attract a large audience in biotech, pharma, start-ups, investors, and research and technology companies from around the world. The conference and exhibition will host over 1000 attendees, 250 speakers, and 80 sponsors and exhibitors. More than 500 different global companies are represented every year at this event.

CRISPRcon: Conversations on Science, Society and the Future of Gene Editing

June 20–21, 2019

CRISPRcon: Conversations on Science, Society and the Future of Gene Editing returns June 20-21, 2019 in Wageningen, the Netherlands to advance broad dialogue on whether and how gene editing technologies should make the transition from the lab into society at large. Please plan to join us for a dynamic, diverse and provocative lineup of panels, keynotes, interactive discussions and networking opportunities that consider gene editing across a variety of applications, disciplines, geographies, communities, cultures and perspectives. Registration opens January 7, 2019.